SARS-Cov-2 Spike binding to ACE2 is stronger and longer ranged with glycans

Yihan Huang; Bradley S Harris; Shiaki A Minami; Seongwon Jung; Priya Shah; Somen Nandi; Karen McDonald; Roland Faller.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-452507

Documentos relacionados

  1. SARS-CoV-2 spike binding to ACE2 is stronger and longer ranged due to glycan interaction.
  2. Entropic contribution of ACE2 glycans to RBD binding.
  3. Plant lectins as versatile tools to fight coronavirus outbreaks.
  4. Analysis of the N-glycosylation profiles of the spike proteins from the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2.
  5. Uncovering the Role of <i>N</i>-Glycan Occupancy on the Cooperative Assembly of Spike and Angiotensin Converting Enzyme 2 Complexes: Insights from Glycoengineering and Native Mass Spectrometry.
  6. Elucidation of <i>N</i>-/<i>O</i>-glycosylation and site-specific mapping of sialic acid linkage isomers of SARS-CoV-2 human receptor angiotensin-converting enzyme 2.
  7. Mechanistic insights into ligand dissociation from the SARS-CoV-2 spike glycoprotein.
  8. Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry.
  9. Structure adaptation in Omicron SARS-CoV-2/hACE2: Biophysical origins of evolutionary driving forces.